These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 17168644)

  • 21. Cellular pathogenesis of Alzheimer's disease.
    Sloop GD
    Med Hypotheses; 1999 Aug; 53(2):127-9. PubMed ID: 10532706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal and pathological Tau proteins as factors for microtubule assembly.
    Delacourte A; Buée L
    Int Rev Cytol; 1997; 171():167-224. PubMed ID: 9066128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau protein and neurodegeneration.
    Kosik KS
    Mol Neurobiol; 1990; 4(3-4):171-9. PubMed ID: 2135393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies].
    Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D
    Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease.
    Hanger DP; Seereeram A; Noble W
    Expert Rev Neurother; 2009 Nov; 9(11):1647-66. PubMed ID: 19903024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau aggregation in Alzheimer's disease: what role for phosphorylation?
    Lippens G; Sillen A; Landrieu I; Amniai L; Sibille N; Barbier P; Leroy A; Hanoulle X; Wieruszeski JM
    Prion; 2007; 1(1):21-5. PubMed ID: 19164903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p70 S6 kinase and tau in Alzheimer's disease.
    Pei JJ; Björkdahl C; Zhang H; Zhou X; Winblad B
    J Alzheimers Dis; 2008 Aug; 14(4):385-92. PubMed ID: 18688088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tubulin-independent tau in Alzheimer's disease and cancer: implications for disease pathogenesis and treatment.
    Souter S; Lee G
    Curr Alzheimer Res; 2010 Dec; 7(8):697-707. PubMed ID: 20678073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau phosphorylation and aggregation in Alzheimer's disease pathology.
    Avila J
    FEBS Lett; 2006 May; 580(12):2922-7. PubMed ID: 16529745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
    Laurent C; Buée L; Blum D
    Biomed J; 2018 Feb; 41(1):21-33. PubMed ID: 29673549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.
    Ando K; Oka M; Ohtake Y; Hayashishita M; Shimizu S; Hisanaga S; Iijima KM
    Biochem Biophys Res Commun; 2016 Sep; 478(2):929-34. PubMed ID: 27520376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models reveal role for tau phosphorylation in human disease.
    Götz J; Gladbach A; Pennanen L; van Eersel J; Schild A; David D; Ittner LM
    Biochim Biophys Acta; 2010 Oct; 1802(10):860-71. PubMed ID: 19751831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions and malfunctions of the tau proteins.
    Shahani N; Brandt R
    Cell Mol Life Sci; 2002 Oct; 59(10):1668-80. PubMed ID: 12475178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
    Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP
    Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of tau protein in both physiological and pathological conditions.
    Avila J; Lucas JJ; Perez M; Hernandez F
    Physiol Rev; 2004 Apr; 84(2):361-84. PubMed ID: 15044677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-translational modifications of tau protein.
    Pevalova M; Filipcik P; Novak M; Avila J; Iqbal K
    Bratisl Lek Listy; 2006; 107(9-10):346-53. PubMed ID: 17262986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PKR kinase directly regulates tau expression and Alzheimer's disease-related tau phosphorylation.
    Reimer L; Betzer C; Kofoed RH; Volbracht C; Fog K; Kurhade C; Nilsson E; Överby AK; Jensen PH
    Brain Pathol; 2021 Jan; 31(1):103-119. PubMed ID: 32716602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of tau kinases in Alzheimer's disease.
    Dolan PJ; Johnson GV
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):595-603. PubMed ID: 20812151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.